IDEAYA Biosciences أخبار Eulerpool

IDEAYA Biosciences إيولربول AFX

أخبار سهم IDEAYA Biosciences

يتابع IDEAYA Biosciences العديد من الصحفيين والمستثمرين حول العالم. نقدم هنا أحدث أخبار IDEAYA Biosciences.

• ١٠ يوليو ·

  Yahoo
  IDEAYA Announces Pricing of Public Offering
• ٩ يوليو ·

  Yahoo
  IDEAYA Biosciences reports positive data from Phase II trial of cancer treatment
• ٨ يوليو ·

  SeekingAlpha
  Ideaya Biosciences: Poised For Success In Bladder And Lung Cancer?
• ٨ يوليو ·

  Yahoo
  IDEAYA Announces Positive Interim Phase 2 Monotherapy Expansion Data for IDE397 a Potential First-in-Class MAT2A Inhibitor in MTAP-Deletion Urothelial and Lung Cancer
• ٥ يوليو ·

  Yahoo
  IDEAYA Announces Investor Webcast to Report Clinical Data Update for IDE397 Phase 2 Monotherapy Expansion Dose in MTAP-Deletion Urothelial and Lung Cancer on Monday, July 8, 2024
• ٢٦ يونيو ·

  Yahoo
  IDEAYA Biosciences initiates subject dosing in Phase I bladder cancer trial
• ٢٥ يونيو ·

  Yahoo
  IDEAYA Biosciences Announces First-Patient-In for Phase 1 Clinical Trial Evaluating IDE397 and Trodelvy® Combination in MTAP-Deletion Bladder Cancer
• ٢٤ يونيو ·

  Yahoo
  IDEAYA Biosciences Announces Clinical Program Updates for IDE397 a Potential First-in-Class Phase 2 MAT2A Inhibitor Targeting MTAP-Deletion Solid Tumors
• ٢٠ يونيو ·

  Market News Video
  IDEAYA Biosciences Breaks Below 200-Day Moving Average - Notable for IDYA
• ١٨ يونيو ·

  Yahoo
  Investors in IDEAYA Biosciences (NASDAQ:IDYA) have seen impressive returns of 277% over the past five years